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DruQuaR
A HPLC/UV/ESI-MS N-alkylamide profiling of a commercial 65% ethanolic Spilanthes extract was performed using a prevail RPC18 (250 × 4.6 mm, 5 µm)
column with an optimized gradient. In-vitro penetration studies using static Franz diffusion cells (diffusional area = 0.64 cm²) were performed. The EtOH in
the extract was evaporated and the residue was redissolved in different PG aqueous solutions. 500 µL of these liquid formulations and 0.5 g of
commercially available mouth gels were applied on dermatomed (~400 µm) human abdominal skin and/or porcine mucosa. The spilanthol content in the
FDC receptor fluid was assayed using a isocratic high throughput HPLC-UV method, with a Lichrospher 100 RP C18 (150 mm x 2 mm, 5 µm) and
Symmetry 100 RP C18 (150 mm x 2 mm, 5 µm) column. The mobile phase consisted of 1% formic acid in MeOH/H2O (72.5 ± 2.5/32.5 ± 2.5, V/V). PBS,
PBS + 1% hydroxypropyl-β-cyclodextrine (HPBCD) and EtOH/H2O (30:70, V/V) were used as receptor phase in the skin experiments, while only PBS +
1% HPBCD was used in the buccal mucosa experiments. To investigate the 100% aqueous delivery, 10 and 30% PG solutions were used as donor phase,
with PBS + HPBCD as receptor fluid: extrapolation to 0% PG gave the 100% aqueous delivery.
EXPERIMENTAL 
[1] J. Boonen, B. Baert, N. Roche, C. Burvenich and B. De Spiegeleer. Transdermal behaviour of the N-alkylamide spilanthol (affinin) from Spilanthes
acmella (Compositae) extracts, J. Ethno-Pharmacology (2009), doi: 10.1016/j.jep.2009.09.046
RESULTS and DISCUSSION 
Figure 2 : TIC-MS chromatogram of the identified N-alkylamides in ethanolic Spilanthes
extract (left) with their MS spectra (right).
A. LC-MS PROFILING
Using HPLC-ESI-MS, 11 N-alkylamides were detected in ethanolic Spilanthes extract: eight N-isobutylamides, two 2-methylbutylamides and one 2-
phenylethylamide. Two new N-isobutylamides were identified. Moreover, we demonstrated and quantified that spilanthol can permeate both skin and 
mucosa in a formulation dependent way.
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CONCLUSIONS
REFERENCES
N-alkylamides are a group of bioactive molecules found in several plants. Extracts and formulations
derived from these plants are not only used orally, but are applied on the skin and buccal mucosa as
well. However, there is no specific information available about the intrinsic local pharmacokinetics of
N-alkylamides after topical application, questioning the role of this mode of administration. Therefore,
we investigated the transdermal and transmucosal behaviour of spilanthol, a prominent N-alkylamide,
in a commercial Spilanthes extract, two mouth gels and different propylene glycol (PG)/H20 solutions.
B. TRANSDERMAL BEHAVIOUR
We demonstrated that spilanthol permeates the human skin. Partitioning
was strongly dependent upon the donor-vehicle composition, while
diffusion was mainly influenced by the receptor fluid composition. Human
skin Kp,aq (± SEM) is 3.31 (± 0.28) · 10-3 cm/h [1].
C. TRANSMUCOSAL BEHAVIOUR
Figure 1 : Spilanthol
Nine N-alkylamides structures could be identified, with spilanthol as most 
abundant alkylamide (± 80%). Two new (i.e. not yet identified in ethanolic
Spilanthes extracts) CID N-isobutylamides were detected:
1. compound 8 (at 70.5 min): based upon the fragment ions, the alkyl 
portion for the m/z=224 isobutylamide is suggested to be a C10H15 diene
structure and has a structure formula of C14H25NO.
2. compound 10 (at 74.3 min): the isobutylamide with m/z=220 possesses a 
structure formula of C14H21NO, with an alkyl chain probably being a 
tetraene.
Further structure elucidation of these two new N-isobutylamides is on-going.
For the first time, it is demonstrated that spilanthol permeates 
mucosa (Fig. 3). Gel 1 (Indolphar®) is adequate to achieve local 
effects, while gel 2 (Buccaldol®) realizes more systemic effects. A 
solvent influence is seen with a two times lower permeability for 
spilanthol in the 65% ethanolic extract compared to 10 and 30% PG 
based extracts. No influence of the percentage PG (in a range of 10 
to 30%) was observed (Fig. 4).
Porcine buccal mucosa Kp,aq (± SEM) = 11.293 (± 0.403) · 10-3 cm/h.
Figure 3: Mean cumulative amount vs. time curves for spilanthol using different 
dose solutions.
Figure 4: Kp of spilanthol for the different formulations.
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